These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9133686)
1. Regulations for radioiodine therapy in the United States: current status and the process of change. Vetter RJ Thyroid; 1997 Apr; 7(2):209-11. PubMed ID: 9133686 [TBL] [Abstract][Full Text] [Related]
2. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association. ; Sisson JC; Freitas J; McDougall IR; Dauer LT; Hurley JR; Brierley JD; Edinboro CH; Rosenthal D; Thomas MJ; Wexler JA; Asamoah E; Avram AM; Milas M; Greenlee C Thyroid; 2011 Apr; 21(4):335-46. PubMed ID: 21417738 [TBL] [Abstract][Full Text] [Related]
4. Regulations and policies on radioiodine 131I therapy in Europe. Beckers C Thyroid; 1997 Apr; 7(2):221-4. PubMed ID: 9133689 [TBL] [Abstract][Full Text] [Related]
5. Radiation dose to patients and relatives incident to 131I therapy. Zanzonico PB Thyroid; 1997 Apr; 7(2):199-204. PubMed ID: 9133684 [TBL] [Abstract][Full Text] [Related]
7. [Exposure of relatives of patients after stationary radioiodine therapy by inhalation of 131I in their homes]. Wellner U; Eschner W; Hillger HW; Schicha H Nuklearmedizin; 1998 May; 37(3):113-9. PubMed ID: 9604232 [TBL] [Abstract][Full Text] [Related]
9. Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family members. Rutar FJ; Augustine SC; Colcher D; Siegel JA; Jacobson DA; Tempero MA; Dukat VJ; Hohenstein MA; Gobar LS; Vose JM J Nucl Med; 2001 Jun; 42(6):907-15. PubMed ID: 11390555 [TBL] [Abstract][Full Text] [Related]
10. Licensee over-reliance on conservatisms in NRC guidance regarding the release of patients treated with 131I. Siegel JA; Marcus CS; Stabin MG Health Phys; 2007 Dec; 93(6):667-77. PubMed ID: 17993847 [TBL] [Abstract][Full Text] [Related]
11. Thyroid cancer: radiation safety precautions in 131I therapy based on actual biokinetic measurements. Liu B; Peng W; Huang R; Tian R; Zeng Y; Kuang A Radiology; 2014 Oct; 273(1):211-9. PubMed ID: 24895877 [TBL] [Abstract][Full Text] [Related]
12. Measurement of the activity of radiopharmaceutical dosages: Nuclear Regulatory Commission. Proposed rule. Fed Regist; 1981 Sep; 46(169):43840-2. PubMed ID: 10252126 [TBL] [Abstract][Full Text] [Related]
13. The need for better methods to determine release criteria for patients administered radioactive material. Sparks RB; Siegel JA; Wahl RL Health Phys; 1998 Oct; 75(4):385-8. PubMed ID: 9753361 [TBL] [Abstract][Full Text] [Related]
14. Treatment of thyroid carcinoma: emphasis on high-dose 131I outpatient therapy. Parthasarathy KL; Crawford ES J Nucl Med Technol; 2002 Dec; 30(4):165-71; quiz 172-3. PubMed ID: 12446749 [TBL] [Abstract][Full Text] [Related]
15. Radioactivity in municipal sewage and sludge. Martin JE; Fenner FD Public Health Rep; 1997; 112(4):308-16; discussion 317-8. PubMed ID: 9258296 [TBL] [Abstract][Full Text] [Related]
16. Establishing a threshold for 131I bioassay in nuclear medicine personnel. Liang Y; Chu RY; Galbraith WK; Macdurmon GW; Sonnad JR Health Phys; 2008 Nov; 95(5 Suppl):S175-9. PubMed ID: 18849711 [TBL] [Abstract][Full Text] [Related]